Testing Strategies for Weight Loss, II
1 other identifier
interventional
66
1 country
1
Brief Summary
In the pilot study, Testing Strategies for Weight Loss, we tested two different approaches using financial incentives to encourage weight loss. In the first, we built on previous work showing the effectiveness of 'deposit contracts', in which subjects are given the opportunity to put their own money at risk if they do not lose weight. In this incentive condition, subjects received a direct payment conditional on daily weight loss, and an optional additional payment based on their own contributions to the deposit contract. We matched their contribution 1:1 to make the option of depositing their own money attractive to this predominantly low SES population. In the second approach we built on our own prior work using lotteries to promote drug adherence. In this incentive condition, participants are entered into a daily lottery, and receive any payoffs they earn from the lottery only if they stay on track with their weight-loss goal. Given their popularity in the general population, lotteries hold the promise of providing a cost-effective means of motivating weight loss and making efforts to lose weight more salient to obese patients. Results from this trial indicate significantly higher weight loss in the incentive arms of the trial than in the control group. The low lost to follow-up rates suggest that this approach to providing daily feedback to keep weight loss salient among participants is feasible. Incentive participants who completed the study called in their daily weights an average 95.8% of the time. 17/19 (89.4%) of subjects deposited money in their deposit contracts and 14/17 participants who made initial deposits either held constant or increased their contributions each month. Subjects in both incentive groups lost significantly more weight on average than subjects in the control group (4.0 lbs) (lottery 13.1 lbs, p = 0.015; deposit contract 14.0 lbs, p = 0.003). Of the subjects not lost to follow-up in the two incentive arms (32 out of 38), all of them lost weight. Based on this promising preliminary evidence and supplemental funding from the Hewlett Foundation, we propose an 8-month study with 2 intervention arms to further examine the effect of incentives on long term weight loss success. This study will build on the work to date to examine which intervention is most successful in promoting sustained weight loss. The proposed 3-arm extension will enroll 66 participants from Philadelphia VA with BMIs between 30 and 40, starting with those potential participants who were placed on a waiting list for our previous study after an overwhelming response to the initial mailing.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_1 obesity
Started Jun 2008
Typical duration for phase_1 obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 20, 2008
CompletedStudy Start
First participant enrolled
June 1, 2008
CompletedFirst Posted
Study publicly available on registry
August 21, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2010
CompletedDecember 6, 2016
December 1, 2016
1 year
May 20, 2008
December 5, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
actual weight loss
eight months
Study Arms (3)
1
ACTIVE COMPARATORdeposit based incentive
2
ACTIVE COMPARATORdeposit based incentive framed with "maintenance" period
3
NO INTERVENTIONControl arm, no financial incentive
Interventions
Eligibility Criteria
You may qualify if:
- BMI between 30-40;
- Age between 30-70;
- At least moderately interested in losing weight (Self-reported 3,4, or 5 on 5 point scale)
You may not qualify if:
- Unstable medical conditions that would likely prevent the subject from completing the study;
- Myocardial infarction within 6 months;
- Uncontrolled hypertension, defined as BP\>170 mm Hg systolic or BP\>110 mm Hg diastolic;
- Diabetic using any medicine besides metformin to control blood sugars
- Metastatic cancer;
- Self-report of 6 or more alcoholic beverages per day;
- Severe depression;
- Active substance abuse;
- Schizophrenia
- Inability to read or severe cognitive deficits that would preclude ability to read consent form or fill out surveys).
- Participation in another research study unless copy of consent form obtained and screened for possible confounding of results.
- Those currently enrolled in a weight loss program elsewhere.
- Pregnant women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Pennsylvanialead
- William and Flora Hewlett Foundationcollaborator
Study Sites (1)
Philadelphia Veterans Administration Medical Center
Philadelphia, Pennsylvania, 19104, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kevin Volpp, MD PhD
Philadelphia Veterans Administration Medical Center
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 20, 2008
First Posted
August 21, 2008
Study Start
June 1, 2008
Primary Completion
June 1, 2009
Study Completion
January 1, 2010
Last Updated
December 6, 2016
Record last verified: 2016-12